Search

Stock Insights on NuVasive, Inc. (NASDAQ:NUVA)

Confidential

April 3, 2015

By Justin Cohen Article: Several analysts have recently weighed on NuVasive, Inc. (NASDAQ:NUVA), issuing notes to investors. William Plovanic of Canaccord Genuity reiterated their Buy rating on the stock yesterday with a $54.00 price target, or 26.26% upside to the

Orthofix secures option to acquire eNeura for $65 million

Confidential

April 3, 2015

By Jessica Achtsam On March 31, 2015, Orthofix International N.V. announced it entered into an 18-month option agreement to acquire eNeura, Inc. Orthofix’s website states that the focus of the company is on “improving patients’ lives by providing superior reconstructive and regenerative orthopedic

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1